Technical Analysis for ERGO - Entia Biosciences, Inc

Grade Last Price % Change Price Change
grade A 0.013 96.97% 0.0064
ERGO closed up 96.97 percent on Wednesday, March 25, 2020, on 52 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ERGO trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 96.97%
Wide Bands Range Expansion 96.97%
Older signals for ERGO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Entia Biosciences, Inc. develops pharmaceutical-grade organic compounds, including a foundational compound called ErgoD2. The Company also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The Company's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The Company's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.
Health Pharmaceutical Industry Pharmacy Nutraceutical Nutraceuticals Chronic Kidney Disease Anemia Holomycota Mushroom

Is ERGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.05
52 Week Low 0.0051
Average Volume 57,808
200-Day Moving Average 0.0141
50-Day Moving Average 0.0119
20-Day Moving Average 0.0097
10-Day Moving Average 0.0088
Average True Range 0.0037
ADX 12.09
+DI 38.6100
-DI 36.2934
Chandelier Exit (Long, 3 ATRs ) 0.0057
Chandelier Exit (Short, 3 ATRs ) 0.0175
Upper Bollinger Band 0.0150
Lower Bollinger Band 0.0044
Percent B (%b) 0.81
BandWidth 109.2784
MACD Line -0.0012
MACD Signal Line -0.0013
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0130
Resistance 3 (R3) 0.0130 0.0130 0.0130
Resistance 2 (R2) 0.0130 0.0130 0.0130 0.0130
Resistance 1 (R1) 0.0130 0.0130 0.0130 0.0130 0.0130
Pivot Point 0.0130 0.0130 0.0130 0.0130 0.0130
Support 1 (S1) 0.0130 0.0130 0.0130 0.0130 0.0130
Support 2 (S2) 0.0130 0.0130 0.0130 0.0130
Support 3 (S3) 0.0130 0.0130 0.0130
Support 4 (S4) 0.0130